Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 134:
135. The compound of claim 125, wherein the compound is of formula (II-A-2):, , or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof,
wherein:
R2 is OR2f, azetidinyl, pyrrolidinyl, piperidinyl, morpholinyl, indolin-4-yl, indolin-5-yl, indolin-6-yl, or indolin-7-yl:
wherein the azetidinyl, pyrrolidinyl, piperidinyl, morpholinyl, indolin-4-yl, indolin-5-yl, indolin-6-yl, or indolin-7-yl is optionally substituted by 1, 2, 3, or 4 independently selected R2e substituents; and

R2f is azetidinyl, pyrrolidinyl, or piperidinyl, wherein the azetidinyl, pyrrolidinyl, or piperidinyl is optionally substituted by 1, 2, 3, or 4 independently selected R2i substituents.